Increased soluble urokinase plasminogen activator receptor (suPAR) serum levels after granulocyte colony-stimulating factor treatment do not predict successful progenitor cell mobilization in vivo.
Fietz
Thomas
T
Hattori
Koichi
K
Thiel
Eckhard
E
Heissig
Beate
B
D015415:Biomarkers / Q000097:blood; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods; D006801:Humans; D007279:Injections, Subcutaneous; D007937:Leukapheresis / Q000379:methods; D008297:Male; D011237:Predictive Value of Tests; D011956:Receptors, Cell Surface / Q000097:blood*; D055293:Receptors, Urokinase Plasminogen Activator
D015415:Biomarkers; C524898:PLAUR protein, human; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D016179:Granulocyte Colony-Stimulating Factor